Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01406795 · ClinicalTrials.gov registry record · NA
The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses
A NA study, sponsored by Stanford University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT01406795: Clinical Trial NA study, sponsored by Stanford University.
NCT01406795 is a NA study that was terminated before completion, run by Stanford University. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01406795, a NA study, was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although performed by some practitioners, has not yet been studied in detail.
Interventions
- DEVICE Gore Viabahn Heparin Coated Stent
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2010-12 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01406795
The ClinicalTrials.gov registry entry for NCT01406795 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Gore Viabahn Heparin Coated Stent is the first listed.
NCT01406795 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01406795 about?
NCT01406795 is a clinical study titled "The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses". To study the safety and efficacy of drug coated stents for the treatment of venous occlusions and stenoses in the lower extremity. The use of the device for the treatment of peripheral arterial disease is approved by the FDA, however, the use of the device in venous occlusions and stenoses, although...
What is the current status of trial NCT01406795?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2010-12. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01406795?
The interventions under investigation include: Gore Viabahn Heparin Coated Stent (DEVICE).
Who is sponsoring clinical trial NCT01406795?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.